Clinical Trials

Showing 301 - 320 of 522 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097]
Drilon, Alexander
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051]
Koehne, Guenther
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Hematology
    • Multiple Myeloma
A Phase II Study of Buparlisib in Patients with Recurrent or Persistent Central Nervous System (CNS) Lymphoma
Relapsed/Refractory
[Protocol 14-177]
Grommes, Christian
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016]
Giralt, Sergio
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201]
Hamlin, Paul
  • Lymphoma
    • Hodgkin's Disease
A Phase II Study of Bortezomib/Dexamethasone Followed by Lenalidomide in Nonresponders as Initial Treatment for Multiple Myeloma
[Protocol 13-064]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of BMN 673 (Talazoparib) in Patients with Locally Advanced or Metastatic Breast Cancer Containing a BRCA Mutation
[Protocol 14-253]
Robson, Mark
  • Breast Cancer
A Phase II Study of BGJ398 in Patients with Persistent Bile Duct Cancer Containing an FGFR Gene Alteration
[Protocol 14-183]
Lowery, Maeve
  • Hepatobiliary
  • Upper Gastrointestinal
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase II Study of AZD1775 plus Chemotherapy Versus Chemotherapy Alone in Patients with TP53-Mutated Ovarian, Fallopian Tube, or Peritoneal Cancer
[Protocol 14-268]
Cadoo, Karen
  • Ovarian Cancer
A Phase II Study of Axitinib plus Dalantercept or Placebo for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin
  • Kidney Cancer
A Phase II Study of AMG 337 in Patients with Stomach and Esophageal Cancers with High Levels of the MET Protein
[Protocol 13-261]
Ku, Geoffrey
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187]
Scher, Howard
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase II Study of Abiraterone with or without Cabazitaxel in Patients with Metastatic Castration-Resistance Prostate Cancer
[Protocol 14-046]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study of Abiraterone Acetate without Simultaneous Prednisone in Men with Castration-Resistant Prostate Cancer, with Hormonal Assessment During Treatment
[Protocol 14-188]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study of a Pediatric-Inspired Combination Chemotherapy Regimen in Adults with Acute Lymphoblastic Leukemia
[Protocol 12-266]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
[Protocol 13-192]
Tamari, Roni
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Comparing Three New Approaches for Preventing Graft-versus-Host Disease
[Protocol 14-197]
Giralt, Sergio
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Blood and Marrow Transplantation
    • Transplantation
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma